Rivaroxaban-Associated Bullous Pemphigoid in a Patient With Atrial Fibrillation
Rivaroxaban is commonly used for prevention of thromboembolic diseases in patients with atrial fibrillation. We report a case of an 86-year-old man with hypertension, chronic kidney disease, type 2 diabetes mellitus, dyslipidemia, and atrial fibrillation who developed bullous eruptions 1 week after...
Guardado en:
Autores principales: | Jiaming (Calvin) Liang, MD, MSc, Karanvir Raman, BBA, Siu Him Chan, MD, A. Yashar Tashakkor, MD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ef1e42bf9baa41a2a73ffa36a56ac722 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
What is Standard Dose of Rivaroxaban in Elderly Asian Patients with Atrial Fibrillation: 20ms versus. 15mg?
por: Sung Soo Kim MD, et al.
Publicado: (2021) -
Clinical Significance of Atrial Fibrillation Status in Patients With Percutaneous Coronary Intervention
por: Toka Hamaguchi, MD, et al.
Publicado: (2021) -
The Association of Atrial Fibrillation Before Percutaneous Coronary Intervention With 1-Year Outcome in ST-Elevation Myocardial Infarction Patients
por: Eero Anttonen, MD, et al.
Publicado: (2021) -
Atrial Myopathy Underlying Atrial Fibrillation
por: Harold Rivner, et al.
Publicado: (2020) -
Satisfaction With Oral Anticoagulants Among Patients With Atrial Fibrillation: A Prospective Observational Study
por: Shahrzad Salmasi, Msc, et al.
Publicado: (2021)